Drugs Made In America Acquisition II Current Assets

As of the most recent data (June 2026), DMIIR shows a current assets of $220K. That compares with $12K in the prior-year period — up 1782.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMIIR's current assets is now $220K (was $12K) — a 1782.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Drugs Made In America Acquisition II is outperforming or lagging.

Tracking DMIIR's current assets over time shows whether Drugs Made In America Acquisition II is scaling, shrinking, or reshaping that part of the business. The current reading is $220K That compares with $12K in the prior-year period — up 1782.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Drugs Made In America Acquisition II's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $220K) with ownership activity and broader fundamentals.